Company profile: Halo Labs
1.1 - Company Overview
Company description
- Provider of biopharmaceutical quality control tools and particle analysis systems using optics, image processing, and microfluidics. Offerings include Aura+ analyzers; Aura PTx for protein therapy stability; Aura GT for viral vector stability; Aura CL for cell therapy particle characterization; Particle Vue software (21 CFR Part 11); and 0.8 µm black membrane plates.
Products and services
- Aura+: A particle analyzer supporting a range of therapeutic approaches, delivering high-throughput particle characterization for proteins, cells, and gene therapies using advanced optics, image processing, and microfluidics with industrial-grade architecture
- Aura PTx: Engineered for protein therapy quality measurements, it detects, counts, and characterizes particles to deliver detailed insights into drug stability with custom-engineered precision
- Aura GT: Specialized for gene therapy applications, it enables viral vector stability analysis with minimal sample requirements using microfluidics-enabled optics and image processing for high-throughput assessments
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Halo Labs
ThermoGenesis
HQ: United States
Website
- Description: Provider of automated technologies for cell-based therapeutics and bioprocessing, including BioArchive for computer-controlled preservation of cells with traceability; X-LAB for rapid, closed-system mononuclear cell isolation; PXP-1000 for automated cord blood stem cell processing; 3D Bag Set for buffy coat transfer with sterile cryoprotectant addition for long-term storage; and cleanroom and wet lab facilities for life science startups.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ThermoGenesis company profile →
Gyros Protein Technologies
HQ: United States
Website
- Description: Provider of peptide synthesizers, reagents, and bioanalysis platforms for universities, biotechnology and pharmaceutical companies, and peptide houses. Offers automated peptide synthesis systems for discovery to pre-clinical studies, Gyrolab systems for high-throughput immunoassays for impurity analysis and titer quantification, PurePep EasyClean kits for catch-and-release peptide purification, and IQ/OQ services for compliant installation and operation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gyros Protein Technologies company profile →
Parallel Bio
HQ: United States
Website
- Description: Provider of startup accelerator services that identify new business ideas, develop and launch new products and services, and review customer feedback and analyze metrics to transform and improve its businesses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parallel Bio company profile →
DCN Diagnostics
HQ: United States
Website
- Description: Provider of lateral flow diagnostics development and manufacturing services, offering contract assay development across lateral flow, flow-through, dry chemistry, and microfluidic formats; design and integration of custom point-of-use readers and lab-on-a-chip systems; scalable manufacturing from clinical trials to commercialization; user-friendly sample collection devices and cartridges; and visual/fluorescent labeling and reporting solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DCN Diagnostics company profile →
ActivX Biosciences
HQ: United States
Website
- Description: Provider of biopharmaceutical discovery and development of highly selective, best-in-class small molecule drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ActivX Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Halo Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Halo Labs
2.2 - Growth funds investing in similar companies to Halo Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Halo Labs
4.2 - Public trading comparable groups for Halo Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →